David is a Ph.D. student in the Aceto lab. He studied pharmaceutical sciences at the University of Freiburg, Germany. During his studies he evaluated Nanopore sequencing as a platform to investigate epigenetic remodeling in chronic heart disease at the Department of Experimental Pharmacology and Toxicology. Before joining the Aceto lab, David completed his pharmaceutical traineeship at Pfizer and obtained his professional pharmacist license. His doctoral work focuses on uncovering targetable vulnerabilities in metastasis-relevant tumor subpopulations through a custom experimental and computational framework that integrates 3D spatial multiomics with spatial lineage tracing approaches.